| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 8.3e-05 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 3.6e-05 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -7.5e-06 | 1 |